title: Managing the warfarinized urological patient.
authors.affiliation: Bristol Urological Institute, Southmead Hospital, Westbury-on-Trym, UK. jpmeyer@doctors.org.uk
authors.forename: J-P
authors.initials: JP
authors.lastname: Meyer
authors.forename: D A
authors.initials: DA
authors.lastname: Gillatt
authors.forename: R
authors.initials: R
authors.lastname: Lush
authors.forename: R
authors.initials: R
authors.lastname: Persad
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation / Q000188:drug therapy; D000075202:Contraindications; D006493:Heparin / Q000008:administration & dosage; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D019106:Postoperative Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D012307:Risk Factors; D020521:Stroke / Q000139:chemically induced; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control; D014570:Urologic Diseases / Q000601:surgery*; D016306:Vena Cava Filters; D014859:Warfarin
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin; D006493:Heparin